Helio Genomics announced a partnership with Ohio-based LiverRight Inc. to integrate its new early liver cancer detection test ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR ...

The discovery began, as many breakthroughs do, with an observation that didn’t quite make sense. In 1948, two French researchers, Paul Mandel and Pierre Métais, published a little-noticed paper in a ...

Conventional diagnostic tools, such as ultrasound, MRI, PET, CT scans, and scintigraphy, often identify cancer only at later stages. These methods can be expensive, expose patients to radiation, and ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

Researchers at Michigan State University created an insect brain-based gas sensing platform to detect lung cancer cell lines. With more development, the technology could be used to detect cancer and ...

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: ...